Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christopher H Stuart"'
Autor:
Christopher H Stuart, Kathryn R Riley, Olcay Boyacioglu, Denise M Herpai, Waldemar Debinski, Shadi Qasem, Frank C Marini, Christa L. Colyer, William H Gmeiner
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
Breast cancer (BC) results in ≃40,000 deaths each year in the United States and even among survivors treatment of the disease may have devastating consequences, including increased risk for heart disease and cognitive impairment resulting from the
Externí odkaz:
https://doaj.org/article/c5d25eb2e8074b42a30c604653f5bab8
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Treatment with doxorubicin (Dox) results in serious systemic toxicities that limit effectiveness for cancer treatment and cause long-term health issues for cancer patients. We identified a new DNA aptamer to prostate-specific membrane antigen (PSMA)
Externí odkaz:
https://doaj.org/article/7d9b257cd5734385a7b8d4bd3d11c1f0
Autor:
Joshua Yoho, Christopher H. Stuart, Jessica Palmer, Kevin Wogensthal, Shawn Swavey, Madhuri Kango-Singh, Kristen K. Comfort, Thomas L. Bennett, William H. Gmeiner
Publikováno v:
European Journal of Inorganic Chemistry. 2017:153-159
A new water-soluble zinc(II) porphyrin has been synthesized and characterized by high resolution mass spectroscopy, elemental analysis, and electronic absorption spectroscopy. The zinc(II) porphyrin (ZnPor) is designed with three N-methylated pyridyl
Publikováno v:
Leukemia Research. 39:229-235
The polymeric fluoropyrimidine F10 displays excellent anti-leukemia activity in pre-clinical models of acute myelogenous leukemia (AML) through dual targeting of thymidylate synthase and DNA topoisomerase 1. Here we report that F10 activates the extr
Publikováno v:
The Prostate. 75:360-369
Background Intracellular Zn(2+) levels decrease during prostate cancer progression and agents that modulate intracellular Zn(2+) are cytotoxic to prostate cancer cells by an incompletely described mechanism. F10 is a new polymeric fluoropyrimidine dr
Autor:
Christopher H. Stuart, David A. Horita, Michael J. Thomas, Freddie R. Salsbury, Mark O. Lively, William H. Gmeiner
Publikováno v:
Bioconjugate Chemistry
Doxorubicin (Dox) is widely used for breast cancer treatment but causes serious side- effects including cardiotoxicity that may adversely impact patient lifespan even if treatment is successful. The present invention relates to selective conjugation
Autor:
Ravi Singh, K.C. Balaji, William H. Gmeiner, Thomas L. Smith, Christopher H. Stuart, David L. Caudell, Ralph B. D'Agostino
Publikováno v:
Nanomedicine (London, England). 11(10)
Aim: To evaluate the potential use of zinc chelation for prostate cancer therapy using a new liposomal formulation of the zinc chelator, N,N,N’,N’-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN). Materials & methods: TPEN was encapsulated in non
Autor:
Denise Herpai, Olcay Boyacioglu, Christopher H. Stuart, Christa L. Colyer, Shadi Qasem, Waldemar Debinski, Kathryn R. Riley, William H. Gmeiner, Frank C. Marini
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
Breast cancer (BC) results in similar to 40,000 deaths each year in the United States and even among survivors treatment of the disease may have devastating consequences, including increased risk for heart disease and cognitive impairment resulting f
Autor:
William H, Gmeiner, Olcay, Boyacioglu, Christopher H, Stuart, Jamie, Jennings-Gee, K C, Balaji
Publikováno v:
The Prostate. 75(4)
Intracellular Zn(2+) levels decrease during prostate cancer progression and agents that modulate intracellular Zn(2+) are cytotoxic to prostate cancer cells by an incompletely described mechanism. F10 is a new polymeric fluoropyrimidine drug-candidat
Autor:
James Ross, Christopher H. Stuart, Michael B. Morgan, Kylia Goodner, Elizabeth Stepp, Angela Z. Poole, Ernesto Weil, Cydney Wilbanks
Publikováno v:
PeerJ, Vol 3, p e1371 (2015)
PeerJ
PeerJ
Molecular stress responses associated with coral diseases represent an under-studied area of cnidarian transcriptome investigations. Caribbean Yellow Band Disease (CYBD) is considered a disease ofSymbiodiniumwithin the tissues of the coral hostOrbice